3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
12
Lymphoma
12
Leukemia
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Hodgkin Disease
7
Sarcoma
6
Neoplasms
6
Hematologic Neoplasms
6
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
5
Neuroblastoma
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Myeloproliferative Disorders
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Breast Neoplasms
3
Vomiting
2
Testicular Neoplasms
2
Recurrence
2
Osteosarcoma
2
Neoplasm Metastasis
2
Nausea
2
Burkitt Lymphoma
2
Thalassemia
1
Teratoma
1
Seminoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Interventions
Imatinib Mesylate
6
Cytarabine
5
ponatinib
4
nilotinib
4
venetoclax
3
fludarabine phosphate
3
Mycophenolic Acid
3
thymoglobulin
2
fludarabine
2
enasidenib
2
Methotrexate
2
Lenalidomide
2
Cyclosporine
2
Cyclophosphamide
2
Azacitidine
2
Antilymphocyte Serum
2
quizartinib
1
methanesulfonic acid
1
glasdegib
1
etoposide phosphate
1
daratumumab
1
bosutinib
1
asciminib
1
Whole-Body Irradiation
1
Transplantation
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Standard of Care
1
RFT5-SMPT-dgA immunotoxin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid
×
Mesna
×
Clear all
No trials found.